$45.6 Million is the total value of NanoDimension, Inc.'s 4 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ICOSAVAX INC | $18,964,000 | -69.9% | 2,693,772 | -2.0% | 41.59% | -26.3% | |
| TWST | TWIST BIOSCIENCE CORP | $15,196,000 | -36.2% | 307,740 | 0.0% | 33.32% | +56.1% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $6,952,000 | -46.1% | 1,445,221 | 0.0% | 15.25% | +31.8% | |
| SELB | SELECTA BIOSCIENCES INC | $4,487,000 | -62.3% | 3,647,907 | 0.0% | 9.84% | -7.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICOSAVAX INC | 4 | Q3 2022 | 56.4% |
| TWIST BIOSCIENCE CORP | 4 | Q3 2022 | 44.0% |
| SELECTA BIOSCIENCES INC | 4 | Q3 2022 | 25.2% |
| SQZ BIOTECHNOLOGIES CO | 4 | Q3 2022 | 15.2% |
View NanoDimension, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-23 |
View NanoDimension, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.